Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials
- 3 July 2021
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 21 (7) , 755-778
Abstract
: Nabiximols, a cannabinoid-based oromucosal spray, is indicated as add-on therapy for symptomatic relief of spasticity in persons with multiple sclerosis (MS). This review compiles tolerability an...Keywords
Funding Information
- provided by Rob Furlong and Kerry Dechant on behalf of Content Ed Net
This publication has 46 references indexed in Scilit:
- Effects of cannabis on cognitive function in patients with multiple sclerosisNeurology, 2011
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related PainJournal of Pain and Symptom Management, 2010
- Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic NeuropathyDiabetes Care, 2009
- Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple SclerosisClinical Neuropharmacology, 2009
- Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trialPain, 2007
- Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trialClinical Therapeutics, 2007
- Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosisEuropean Journal of Neurology, 2007
- Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritisRheumatology, 2005
- Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosisNeurology, 2005
- Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trialPain, 2004